A method to optimise the use of a grayshade scale in nuclear medicine images.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 1000968)

Published in Comput Biomed Res on December 01, 1976

Authors

M L Goris, P O Scheibe, J P Kriss

Articles by these authors

Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int (1985) 4.76

Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology (1974) 1.92

Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr (1979) 1.67

Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab (1973) 1.66

Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys (1990) 1.65

Overview of animal studies comparing radioimmunotherapy with dose equivalent external beam irradiation. Radiother Oncol (1992) 1.57

Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. Clin Cancer Res (1996) 1.47

Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: implications for diagnosis and therapy of the disorder. Pediatrics (1965) 1.39

Reproducibility of thallium-201 myocardial imaging. Circulation (1977) 1.36

HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab (1974) 1.33

Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer. Clin Cancer Res (2000) 1.30

Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab (1967) 1.26

Automatic registration and alignment on a template of cardiac stress and rest reoriented SPECT images. IEEE Trans Med Imaging (1997) 1.19

Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin. J Nucl Med (1991) 1.15

Radioisotopic thyroidolymphography in patients with Graves' disease. J Clin Endocrinol Metab (1970) 1.11

Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. J Nucl Med (1985) 1.08

The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients. Cancer (1981) 1.08

Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. Am Heart J (1983) 1.07

Cardiac damage produced by direct current countershock applied to the heart. Am J Cardiol (1979) 1.07

Screening for bone metastases. Are only scans necessary? JAMA (1975) 1.06

Applications of ventilation lung imaging with 81mKrypton. Radiology (1977) 1.06

Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. J Clin Endocrinol Metab (1971) 1.06

Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy). Recent Prog Horm Res (1975) 1.05

Detection, quantitation and pathophysiology of lung "spiders". Trans Assoc Am Physicians (1975) 1.05

The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study. Circulation (1983) 1.04

Computed tomography in orbital pseudothumor (idiopathic orbital inflammation). Radiology (1976) 1.04

Review of a 5-year experience with the radiostrontium bone scintiscan. Calif Med (1972) 1.02

Allogeneic cytolysis of reconstituted membrane vesicles. Proc Natl Acad Sci U S A (1979) 0.98

Radioisotopic angiocardiography: findings in congenital heart disease. J Nucl Med (1972) 0.98

Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma. J Clin Endocrinol Metab (1971) 0.97

Bone marrow regeneration following large field radiation: influence of volume, age, dose, and time. Cancer (1978) 0.96

Interpolative background subtraction. J Nucl Med (1976) 0.94

Thallium-201 myocardial imaging in patients with previous cardiac transplantation. Clin Radiol (1981) 0.94

Distribution and fate of synthetic lipid vesicles in the mouse: a combined radionuclide and spin label study. Proc Natl Acad Sci U S A (1974) 0.93

Detection of occult abscesses with 111In-labeled leukocytes. AJR Am J Roentgenol (1979) 0.93

Noninvasive assessment of donor and native heart function after heterotopic heart transplantation. J Thorac Cardiovasc Surg (1988) 0.92

In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration. J Nucl Med (1975) 0.91

The influence of lipid substitution on thyrotropin-receptor interactions in artificial vesicles. Endocrinology (1977) 0.91

Radioisotopic angiocardiography. Wide scope of applicability in diagnosis and evaluation of therapy in diseases of the heart and great vessels. Circulation (1971) 0.91

Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J Clin Endocrinol Metab (1986) 0.91

Comparative value of maximal treadmill testing, exercise thallium myocardial perfusion scintigraphy and exercise radionuclide ventriculography for distinguishing high- and low-risk patients soon after acute myocardial infarction. Am J Cardiol (1984) 0.91

Myocardial imaging in a patient with reproducible variant angina. Am J Cardiol (1977) 0.90

Interhemispheric asymmetry of regional cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder. Nucl Med Commun (2001) 0.90

Changes in rest and exercise myocardial perfusion and left ventricular function 3 to 26 weeks after clinically uncomplicated acute myocardial infarction: effects of exercise training. Am J Cardiol (1984) 0.90

Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease. J Clin Endocrinol Metab (1973) 0.90

Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies. J Clin Endocrinol Metab (1970) 0.89

HL-A antigens in Japanese Patients with Graves' disease. Tissue Antigens (1975) 0.89

Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci (1983) 0.88

Computed tomography in Graves' ophthalmopathy. Radiology (1976) 0.88

Technetium-99m pyrophosphate myocardial uptake in patients with stable angina pectoris. Am J Cardiol (1977) 0.88

Unruptured aneurysm of the sinus of valsalva producing right ventricular outflow obstruction. Am J Med (1972) 0.88

A shunt is (not) a shunt is (not) a shunt. Am Rev Respir Dis (1977) 0.87

Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves ophthalmopathy. Proc Natl Acad Sci U S A (1979) 0.87

Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding. J Nucl Med (1984) 0.87

Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy. Int J Radiat Oncol Biol Phys (1980) 0.87

Inactivation of long-acting thyroid stimulator (LATS) by anti-kappa and anti-lambda antisera. J Clin Endocrinol Metab (1968) 0.85

Cardiovascular physiology in a case of heterotopic cardiac transplantation. Am J Cardiol (1982) 0.85

Radiometric measurement of thyroglobulin-antithyroglobulin immune complex in human serum. J Clin Endocrinol Metab (1977) 0.85

Sounding board: On white coats and other matters. N Engl J Med (1975) 0.85

Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin. Cancer Biother Radiopharm (1999) 0.85

A fully automated determination of the left ventricular region of interest in nuclear angiocardiography. Cardiovasc Intervent Radiol (1981) 0.84

Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes. Radiology (1984) 0.84

The long-acting thyroid stimulator and thyroid disease. Adv Intern Med (1970) 0.84

Correlation of tumor sensitivity to low-dose-rate irradiation with G2/M-phase block and other radiobiological parameters. Radiat Res (1993) 0.83

Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera. J Clin Endocrinol Metab (1979) 0.83

The diagnosis of intracardiac metastasis of colon carcinoma by radioisotopic and roentgenographic studies. Am J Cardiol (1970) 0.83

Helper and suppressor activities of lymphocyte subsets on antithyroglobulin production in vitro. J Clin Endocrinol Metab (1985) 0.82

Purification of human anti-thyroglobulin. J Clin Endocrinol Metab (1975) 0.81

Tc99m labelled toluidine blue O for liver scintillography. Int J Appl Radiat Isot (1968) 0.81

Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts. Cancer Res (1993) 0.81

In vivo imaging of acute cardiac rejection in human patients using (99m)technetium labeled annexin V. Am J Transplant (2001) 0.81

Mechanisms for decreased exercise capacity after bed rest in normal middle-aged men. Am J Cardiol (1983) 0.81

Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system. IEEE Trans Biomed Eng (1985) 0.81

Improved specificity of prone versus supine thallium SPECT imaging. Clin Nucl Med (1988) 0.81

Preparation of radiolabeled thyroid-stimulating immunoglobulins (TSI) by recombining TSI heavy chains with 125I-labeled light chains: direct evidence that the product binds to the membrane thyrotropin receptor and stimulates adenylate cyclase. Endocrinology (1978) 0.80

Combined superior vena cava obstruction and pericardial effusion demonstrated by radioisotopic angiocardiography. J Nucl Med (1970) 0.80

Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys (1985) 0.80

Determinants of the antitumor effect of radiolabeled monoclonal antibodies. Cancer Res (1990) 0.79

In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids. J Clin Invest (1968) 0.79

Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases. J Clin Endocrinol Metab (1982) 0.79

Radioisotopic angiocardiography. Preoperative and postoperative evaluation of patients with diseases of the heart and aorta. Radiol Clin North Am (1971) 0.79

Peripheral blood lymphocytes from normal individuals can be induced to secrete immunoglobulin G antibodies against self-antigen thyroglobulin in vitro. J Clin Endocrinol Metab (1985) 0.79

Noise analysis of a digital radiography system. AJR Am J Roentgenol (1984) 0.79

Multicompartmental analysis of the kinetics of radioiodinated monoclonal antibody in patients with cancer. J Nucl Med (1986) 0.79

Pyrophosphate retention by previously irradiated renal tissue. Radiology (1979) 0.78

Failure to diagnose cardiac treatment rejection with Tc99m-PYP images. Clin Nucl Med (1981) 0.78

Vesicle interactions with polyamino acids and antibody: in vitro and in vivo studies. J Nucl Med (1975) 0.78

Distribution and scintiphotography of a new complex, pentavalent technetium-99m citrate: studies in the rodent. J Nucl Med (1967) 0.78

99Technetium bone scanning in experimental osteomyelitis. Clin Orthop Relat Res (1977) 0.78

A solid phase, sandwich-type radioimmunoassay for antithyroglobulin: elimination of false positive results and semiquantitative measurement of antithyroglobulin in the presence of elevated thyroglobulin. J Clin Endocrinol Metab (1979) 0.78

Diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study. Acta Pharmacol Toxicol (Copenh) (1985) 0.78

Parathyroid imaging. Use of dual isotope scintigraphy for the localization of adenomas before surgery. Clin Nucl Med (1992) 0.78

New thoughts about the cause and treatment of the severe ocular manifestations of Graves' disease. Scott Med J (1974) 0.77

Goodness-of-fit and local identifiability of a receptor-binding radiopharmacokinetic system. IEEE Trans Biomed Eng (1992) 0.77

Therapy with occlusive dressings of pretibial myxedema with fluocinolone acetonide. J Clin Endocrinol Metab (1967) 0.77

Alteration of mammalian cells by interaction with artificial lipid vesicles. Cancer Res (1976) 0.77